SEC Filings

10-K
ARRAY BIOPHARMA INC filed this Form 10-K on 08/11/2017
Entire Document
 

 
 
 
 
Incorporated by Reference
Exhibit Number
 
Description of Exhibit
 
Form
 
File No.
 
Date Filed
10.72
 
Employment Agreement, dated July 28, 2016, between registrant and Jason Haddock*
 
10-K
 
001-16633
 
8/9/2016
10.73
 
Noncompete Agreement, dated July 28, 2016, between registrant and Jason Haddock*
 
10-K
 
001-16633
 
8/9/2016
10.74
 
Confidentiality and Inventions Agreement, dated July 28, 2016, between registrant and Jason Haddock*
 
10-K
 
001-16633
 
8/9/2016
10.75
 
Loan and Security Agreement dated December 22, 2016 between the registrant and Silicon Valley Bank
 
8-K
 
001-16633
 
12/23/2016
10.76
 
Subordinated Convertible Promissory Note dated September 2, 2016 between the registrant and Redmile Biopharma Investments I, L.P.
 
8-K
 
001-16633
 
9/2/2016
10.77
 
Subordinated Convertible Promissory Notes dated September 2, 2016 between the registrant and Redmile Capital Offshore Fund II, Ltd.
 
8-K
 
001-16633
 
9/2/2016
10.78
 
Note Purchase Agreement dated September 2, 2016 between the registrant and Redmile Biopharma Investments I, L.P. and Redmile Capital Offshore Fund II, Ltd.
 
8-K
 
001-16633
 
9/2/2016
10.79
 
First Amendment to Subordinated Convertible Promissory Notes dated August 7, 2017 between the registrant and Redmile Biopharma Investments I, L.P. and Redmile Capital Offshore Fund II, Ltd.
 
8-K
 
001-16633
 
8/9/2017
10.80
 
License, Development and Commercialization Agreement, dated May 31, 2017, between the registrant and Ono Pharmaceutical Co., Ltd**
 
 
 
Filed herewith
 
 
10.81
 
Clinical Trial Collaboration and Supply Agreement, dated May 4, 2017, between the registrant and Merck Sharp & Dohme B.V.**
 
 
 
Filed herewith
 
 
10.82
 
Second Amendment to Lease, dated April X, 2017, between the registrant and BMR-3200 Walnut Street LLC
 
 
 
Filed herewith
 
 
23.1
 
Consent of KPMG LLP, Independent Registered Public Accounting Firm
 
 
 
Filed herewith
 
 
31.1
 
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended
 
 
 
Filed herewith
 
 
31.2
 
Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended
 
 
 
Filed herewith
 
 
32.1
 
Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
 
 
Furnished
 
 
101.INS
 
XBRL Instance Document
 
 
 
Filed herewith
 
 
101.SCH
 
XBRL Taxonomy Extension Schema Document
 
 
 
Filed herewith
 
 
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document
 
 
 
Filed herewith
 
 
101.LAB
 
XBRL Taxonomy Extension Label Linkbase Document
 
 
 
Filed herewith
 
 
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document
 
 
 
Filed herewith
 
 
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase Document
 
 
 
Filed herewith
 
 
                                      
 
 
 
 
 
 
*     Management contract or compensatory plan.
**    Confidential treatment of redacted portions of this exhibit has been granted.